Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzheng 3
- Development stage
- Unknown
- Lead developer
- Guang'anmen Hospital
- Administration
- Oral
01
Overview
Fuzheng 3 is a Traditional Chinese Medicine (TCM) herbal formula developed by the Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is primarily utilized as an adjunctive therapy for patients with HIV/AIDS, particularly those undergoing Highly Active Antiretroviral Therapy (HAART). The formula is designed according to the TCM principle of "Fuzheng," which focuses on strengthening the body's vital energy and immune resistance. Clinical trials have evaluated Fuzheng 3 for its ability to support immune reconstitution, specifically by increasing CD4+ T-lymphocyte counts and improving the quality of life in patients with suboptimal immune responses (CD4 counts ≤ 350 cells/µl). It is often studied in conjunction with other formulas in the series, such as Fuzheng 1, and is believed to work through multi-target mechanisms to stabilize immune function and potentially inhibit viral replication.
- Other names
- Immunity 3Immunity3Immunity-3
02
Targets
HIV (HIV-1 enzymes)CD4 (T lymphocyte surface antigen)
Beyond the preview
Go deeper on Fuzheng 3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fuzheng 3.